Sussex Research Laboratories Inc. Appoints Dr. Corwin Nycholat to Advisory Board

Sussex Research Laboratories Inc. Appoints Dr. Corwin Nycholat to Advisory Board

Sussex Research Laboratories Inc. (Sussex Research), a global leader in carbohydrate synthesis and the translation of complex carbohydrate chemistries into unique, leading-edge products that enable researchers to explore and exploit glycomics applications that promote human health., is pleased to announce the appointment of Dr. Corwin Nycholat to its Scientific Advisory Board.

“I am delighted to welcome such an accomplished individual to our Board,” said Dr. Brady Clark, President and CEO of Sussex Research. “As the glycomics field advances, and Sussex Research enters a new phase of its strategic growth, it’s vital to have scientists with strong track-records and expertise in the field. I’m pleased to welcome Corwin Nycholat as a Board member, and I am excited to work with Corwin for the years to come.”

Dr. Corwin Nycholat is a veteran carbohydrate synthetic chemist with over 20 years of experience in developing chemical and enzymatic synthetic processes for complex glycans used in biomedical applications for drug delivery, targeting and vaccine development. Dr. Nycholat’s interests have generally been focused on applications in the fields of glycobiology and glycomics, the study of sugars on a molecular level. He served as a Senior Staff Scientist at The Scripps Research Institute (TSRI) working in the laboratory of Professor James C. Paulson. He has extensive research experience in the synthesis, discovery and development of high affinity ligands for targeting lectins including siglecs, galectins and viral hemagglutinins. For 7 years while at TSRI, Dr. Nycholat served as Core Director of the Carbohydrate Synthesis Core under the National Heart, Lung, and Blood Institute funded Lung Inflammatory Disease Program of Excellence in Glycosciences.

Back to blog

About Sussex Research Laboratories Inc.

Sussex Research Laboratories Inc. is a global leader in Carbohydrate Synthesis. We excel at translating complex carbohydrate chemistries into unique, leading-edge products that enable researchers to explore and exploit glycobiology in applications that promote human health. Our product portfolio and contract research & development services enable our clients and partners to apply discoveries in glycomics for drug development & discovery, drug delivery & targeting, vaccine development and monoclonal antibody development. Experience glyco-enhancement of your small molecule, protein, oligonucleotide or other macromolecule through Sussex Research Laboratories Inc.. We are the GalNAc, Glycan, Ligand, Glycopeptide and Glycoconjugate Specialists.

  • Sussex Research Laboratories Inc. to Exhibit at the 9th Annual OPT Congress

    Sussex Research Laboratories Inc. to Exhibit at...

    Sussex Research Laboratories Inc. is excited to announce its sponsorship and participation in the upcoming OPT Congress, the leading conference for advancements in oligonucleotides and mRNA therapeutics. Celebrating its 9th...

    Sussex Research Laboratories Inc. to Exhibit at...

    Sussex Research Laboratories Inc. is excited to announce its sponsorship and participation in the upcoming OPT Congress, the leading conference for advancements in oligonucleotides and mRNA therapeutics. Celebrating its 9th...

  • Sussex Research Laboratories Inc. to Exhibit at Society for Glycobiology's annual meeting Hawaii

    Sussex Research Laboratories Inc. to Exhibit at...

    We're thrilled to announce our participation in the upcoming Society for Glycobiology's annual meeting in beautiful Hawaii from November 5th to 8th. We are excited to have our Chief Scientific Officer,...

    Sussex Research Laboratories Inc. to Exhibit at...

    We're thrilled to announce our participation in the upcoming Society for Glycobiology's annual meeting in beautiful Hawaii from November 5th to 8th. We are excited to have our Chief Scientific Officer,...

  • Sussex Research Laboratories Inc. to Exhibit at BPS 2023 in Napa, California

    Sussex Research Laboratories Inc. to Exhibit at...

    Exciting news awaits! Sussex Research Laboratories Inc. is poised to unveil their pioneering strides in pharmaceutical development of peptide therapeutics at the highly anticipated Boulder Peptide Symposium (BPS) 2023, set...

    Sussex Research Laboratories Inc. to Exhibit at...

    Exciting news awaits! Sussex Research Laboratories Inc. is poised to unveil their pioneering strides in pharmaceutical development of peptide therapeutics at the highly anticipated Boulder Peptide Symposium (BPS) 2023, set...

1 of 3